If you were fixin’ to connect with pulmonary hypertension (PH) patients in June, you would’ve found a whole contingent of us camped out in Dallas. The PH community took the Lone Star State by storm for the Pulmonary Hypertension Association’s biennial International PH Conference and Scientific Sessions. Alongside…
Discussion
Most patients who completed one year in an open-label expanded access program (EAP) of CS1, an experimental oral treatment being developed by Cereno Scientific for pulmonary arterial hypertension (PAH), remained stable or improved on several clinical measures. The EAP (NCT06321705), also known as compassionate use, allowed patients…
Discussion
At the Pulmonary Hypertension Association’s (PHA) biannual conference, it is easy to feel like you should be able to do more. There are sessions to attend, people to meet, dinners to join, and late-night moments you don’t want to miss. There is a kind of magic in being surrounded by…
Discussion
Elevated blood levels of uric acid, a substance often associated with gout, are associated with a higher risk of pulmonary arterial hypertension (PAH) in people of European ancestry, a study suggested. “Our study supports a positive genetic association between [blood uric acid] and PAH risk,” the researchers wrote. “Further…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
